Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

GINKGO BIOWORKS HOLDINGS, INC. (DNA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

GINKGO BIOWORKS HOLDINGS, INC. (DNA), most recent 12 months reported: revenue $111.86M, net loss $290.8M, free cash flow -$174.8M. Latest balance sheet on file: liquid cash $302.16M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Beam Therapeutics Inc. · AGENUS INC · ATARA BIOTHERAPEUTICS, INC. · Autolus Therapeutics plc · Century Therapeutics, Inc. · KYMERA THERAPEUTICS, INC. · 4D Molecular Therapeutics, Inc. · Protalix BioTherapeutics, Inc.

Stock screener

Watchlist